Results 71 to 80 of about 9,872 (99)

Mitomycin C in Photorefractive Keratectomy

Journal of Refractive Surgery, 2009
Purpose: To evaluate the outcome of primary or retreatment photorefractive keratectomy (PRK) or photo-therapeutic keratectomy (PTK) with mitomycin C (MMC) 0.02% applied prophylactically intraoperatively for the prevention of haze and regression in cases of significant haze and regression after primary PRK, due to previous ...
Ashraf Shalaby, Geoffrey B. Kaye, Howard V. Gimbel   +2 more
openaire   +2 more sources

Pharmacokinetics of intraperitoneal mitomycin C

Surgical Oncology Clinics of North America, 2003
The favorable pharmacokinetics of MMC, used during intraperitoneal chemotherapy, has been reported in several studies [11-19]. A major safety issue in studies using intraperitoneal chemotherapy perfusion is the resulting systemic drug exposure. The AUCplasma is determined by the dose, the clearance, and the fraction absorbed from the peritoneal cavity.
Victor J. Verwaal, S. van Ruth, F.A.N. Zoetmulder   +2 more
openaire   +2 more sources

Mitomycin C (z.B. Mitomycin C „Kyowa“)

2006
aufgrund zahlreicher Berichte uber Nekrosen wird Mitomycin C als gewebsnekrotisierend ...
openaire   +2 more sources

Bioactivation and Resistance to Mitomycin C

2004
Publisher Summary This chapter analyzes the bioactivation and resistance of tumor cells to mitomycin C (MC). MC is a naturally occurring antibiotic that was isolated originally from the microorganism Streptomyces caspitosus . MC exerts its antitumor activity primarily by damaging DNA through both monofunctional and bifunctional alkylations (cross ...
Raymond P. Baumann, Philip G. Penketh, Alan C. Sartorelli, Helen A. Seow   +3 more
openaire   +3 more sources

Potential Toxicity of Mitomycin C

Archives of Ophthalmology, 1991
To the Editor. —Chen et al1and Palmer2recently reported on the use of mitomycin C as adjunct chemotherapy during glaucoma filtration surgery. Both investigations followed similar protocols in which the episclera was soaked with a solution of 0.2 to 0.4 mg/mL of mitomycin C for 5 minutes before creating a sclerostomy.
Robert J. Derick, Henry D. Jampel, Louis R. Pasquale, Harry A. Quigley   +3 more
openaire   +3 more sources

Mitomycin C extravasation ulcers

Journal of Surgical Oncology, 1985
AbstractIn a four‐year period, eight patients with mitomycin C extravasation ulcers were encountered. Mitomycin C extravasation produces a painful indolent ulcer that does not have any tendency to heal. If extravasation of the drug is recognized, infusion should be stopped immediately, and the site of infusion should be changed.
Anuradha Khanna, Mahendra Kumar Misra, A. K. Asthana, Ajay K. Khanna   +3 more
openaire   +3 more sources

Intraoperative Mitomycin C in Dacryocystorhinostomy

Ophthalmic Plastic and Reconstructive Surgery, 2001
To assess the efficacy of intraoperative mitomycin C (MMC) in external dacryocystorhinostomy (EXT-DCR).Forty-six cases (50 lacrimal drainage systems [LDS]) with nasolacrimal duct obstruction were randomized into three groups. In the control group, a standard EXT-DCR procedure was performed. In the two MMC groups, a piece of cotton soaked with 0.2 mg/ml
Yi-an You, Chun-ting Fang
openaire   +3 more sources

Mitomycin-C in the postsurgical ear canal

Otolaryngology - Head and Neck Surgery, 2003
OBJECTIVEOur goal was to evaluate the use of topical mitomycin‐C (MMC) in the prevention of scar tissue formation in the postsurgical external auditory canal (EAC).STUDY DESIGN AND SETTINGWe conducted a prospective pilot study at a tertiary care institution.METHODSSix patients with recurrent postoperative granulation tissue after canaloplasty ...
Vishal Banthia, Samuel H. Selesnick
openaire   +3 more sources

Intraoperative Mitomycin C in the Treatment of Pterygium

Cornea, 2000
To evaluate the effectiveness of intraoperative mitomycin C in preventing the recurrence of primary pterygium.In this prospective, randomized study, 38 eyes of 35 patients with primary pterygium were evaluated. In 19 eyes, the "bare sclera technique" combined with intraoperative application of 0.2 mg/mL (0.02%) mitomycin C for five minutes was ...
Yanyali, AC, Karabas, L, Caglar, Y, Manav, G, Alp, BN, Talu, H   +5 more
openaire   +4 more sources

Eosinophilic cystitis induced by Mitomycin-C

International Urology and Nephrology, 1996
Eosinophilic cystitis is an unusual form of cystitis which is characterized by irritative voiding symptoms and haematuria. In the report herein two adult cases of eosinophilic cystitis treated with intravesical Mitomycin-C instillations for prophylaxis of bladder carcinoma are presented and the literature is reviewed.
Apaydin E., Ülker V., Özyurt C., Kandiloglu G., Gürsan A.   +4 more
openaire   +3 more sources